Derivation and validation of three intracerebral hemorrhage expansion scores using different CT modalities.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 09 11 2022
accepted: 13 02 2023
revised: 26 01 2023
medline: 11 8 2023
pubmed: 15 4 2023
entrez: 14 4 2023
Statut: ppublish

Résumé

To derivate and validate three scores for the prediction of intracerebral hemorrhage (ICH) expansion depending on the use of non-contrast CT (NCCT), single-phase CTA, or multiphase CTA markers of hematoma expansion, and to evaluate the added value of single-phase and multiphase CTA over NCCT. After prospectively deriving NCCT, single-phase CTA, and multiphase CTA hematoma expansion scores in 156 patients with ICH < 6 h, we validated them in 120 different patients. Discrimination and calibration of the three scores was assessed. Primary outcome was substantial hematoma expansion > 6 mL or > 33% at 24 h. The evaluation of single-phase and multiphase CTA markers gave a steadily increase in discrimination for substantial hematoma expansion over NCCT markers. The C-index (95% confidence interval) in derivation and validation cohorts was 0.69 (0.58-0.80) and 0.59 (0.46-0.72) for NCCT score, significantly lower than 0.75 ([0.64-0.87], p = 0.038) and 0.72 ([0.59-0.84], p = 0.016) for single-phase CTA score, and than 0.79 ([0.68-0.89], p = 0.033) and 0.73 ([0.62-0.85], p = 0.031) for multiphase CTA score, respectively. The three scores showed good calibration in both derivation and validation cohorts: NCCT (χ This study shows the added prognostic value of more advanced CT modalities in acute ICH evaluation. NCCT, single-phase CTA, and multiphase CTA scores may help to refine the selection of patients at risk of expansion in different decision-making scenarios. • This study shows the added prognostic value of more advanced CT modalities in acute intracerebral hemorrhage evaluation. • The evaluation of single-phase and multiphase CTA markers provides a steadily increase in discrimination for intracerebral hemorrhage expansion over non-contrast CT markers. • Non-contrast CT, single-phase CTA, and multiphase CTA scores may help clinicians and researchers to refine the selection of patients at risk of intracerebral hemorrhage expansion in different decision-making scenarios.

Identifiants

pubmed: 37059906
doi: 10.1007/s00330-023-09621-0
pii: 10.1007/s00330-023-09621-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6045-6053

Informations de copyright

© 2023. The Author(s), under exclusive licence to European Society of Radiology.

Références

Greenberg SM, Ziai WC, Cordonnier C et al (2022) 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the american heart association/american stroke association. Stroke 53:e282–e361
doi: 10.1161/STR.0000000000000407 pubmed: 35579034
Demchuk AM, Dowlatshahi D, Rodriguez-Luna D et al (2012) Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the ct-angiography spot sign (predict): a prospective observational study. Lancet Neurol 11:307–314
doi: 10.1016/S1474-4422(12)70038-8 pubmed: 22405630
Rodriguez-Luna D, Coscojuela P, Rodriguez-Villatoro N et al (2017) Multiphase ct angiography improves prediction of intracerebral hemorrhage expansion. Radiology 285:932–940
doi: 10.1148/radiol.2017162839 pubmed: 28678670
Boulouis G, Morotti A, Charidimou A, Dowlatshahi D, Goldstein JN (2017) Noncontrast computed tomography markers of intracerebral hemorrhage expansion. Stroke 48:1120–1125
doi: 10.1161/STROKEAHA.116.015062 pubmed: 28289239 pmcid: 5378158
Morotti A, Dowlatshahi D, Boulouis G et al (2018) Predicting intracerebral hemorrhage expansion with noncontrast computed tomography: the bat score. Stroke 49:1163–1169
doi: 10.1161/STROKEAHA.117.020138 pubmed: 29669875 pmcid: 6034631
Morotti A, Arba F, Boulouis G, Charidimou A (2020) Noncontrast ct markers of intracerebral hemorrhage expansion and poor outcome: a meta-analysis. Neurology 95:632–643
doi: 10.1212/WNL.0000000000010660 pubmed: 32847959
Arba F, Rinaldi C, Boulouis G, Fainardi E, Charidimou A, Morotti A (2021) Noncontrast computed tomography markers of cerebral hemorrhage expansion: diagnostic accuracy meta-analysis. Int J Stroke 17474930211061639
Yogendrakumar V, Moores M, Sikora L et al (2020) Evaluating hematoma expansion scores in acute spontaneous intracerebral hemorrhage: a systematic scoping review. Stroke 51:1305–1308
doi: 10.1161/STROKEAHA.119.028574 pubmed: 31964287
Rodriguez-Luna D, Coscojuela P, Rubiera M et al (2016) Ultraearly hematoma growth in active intracerebral hemorrhage. Neurology 87:357–364
doi: 10.1212/WNL.0000000000002897 pubmed: 27343067 pmcid: 4977111
Barras CD, Tress BM, Christensen S et al (2009) Density and shape as ct predictors of intracerebral hemorrhage growth. Stroke 40:1325–1331
doi: 10.1161/STROKEAHA.108.536888 pubmed: 19286590
Selariu E, Zia E, Brizzi M, Abul-Kasim K (2012) Swirl sign in intracerebral haemorrhage: definition, prevalence, reliability and prognostic value. BMC Neurol 12:109
doi: 10.1186/1471-2377-12-109 pubmed: 23013418 pmcid: 3517489
Li Q, Zhang G, Huang YJ et al (2015) Blend sign on computed tomography: novel and reliable predictor for early hematoma growth in patients with intracerebral hemorrhage. Stroke 46:2119–2123
doi: 10.1161/STROKEAHA.115.009185 pubmed: 26089330
Blacquiere D, Demchuk AM, Al-Hazzaa M et al (2015) Intracerebral hematoma morphologic appearance on noncontrast computed tomography predicts significant hematoma expansion. Stroke 46:3111–3116
doi: 10.1161/STROKEAHA.115.010566 pubmed: 26451019
Rodriguez-Luna D, Rubiera M, Ribo M et al (2011) Ultraearly hematoma growth predicts poor outcome after acute intracerebral hemorrhage. Neurology 77:1599–1604
doi: 10.1212/WNL.0b013e3182343387 pubmed: 21998314
Thompson AL, Kosior JC, Gladstone DJ et al (2009) Defining the ct angiography “spot sign” in primary intracerebral hemorrhage. Can J Neurol Sci 36:456–461
doi: 10.1017/S0317167100007782 pubmed: 19650356
Brott T, Broderick J, Kothari R et al (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1–5
doi: 10.1161/01.STR.28.1.1 pubmed: 8996478
Wada R, Aviv RI, Fox AJ et al (2007) Ct angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 38:1257–1262
doi: 10.1161/01.STR.0000259633.59404.f3 pubmed: 17322083
Rodriguez-Luna D, Boyko M, Subramaniam S et al (2016) Magnitude of hematoma volume measurement error in intracerebral hemorrhage. Stroke 47:1124–1126
doi: 10.1161/STROKEAHA.115.012170 pubmed: 26892283
Sullivan LM, Massaro JM, D’Agostino RB Sr (2004) Presentation of multivariate data for clinical use: the framingham study risk score functions. Stat Med 23:1631–1660
doi: 10.1002/sim.1742 pubmed: 15122742
Goldstein JN, Fazen LE, Snider R et al (2007) Contrast extravasation on ct angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology 68:889–894
doi: 10.1212/01.wnl.0000257087.22852.21 pubmed: 17372123
Rodriguez-Luna D, Dowlatshahi D, Aviv RI et al (2014) Venous phase of computed tomography angiography increases spot sign detection, but intracerebral hemorrhage expansion is greater in spot signs detected in arterial phase. Stroke 45:734–739
doi: 10.1161/STROKEAHA.113.003007 pubmed: 24481974
Zheng J, Yu Z, Xu Z et al (2017) The accuracy of the spot sign and the blend sign for predicting hematoma expansion in patients with spontaneous intracerebral hemorrhage. Med Sci Monit 23:2250–2257
doi: 10.12659/MSM.901583 pubmed: 28498827 pmcid: 5437917
Morotti A, Boulouis G, Charidimou A et al (2018) Integration of computed tomographic angiography spot sign and noncontrast computed tomographic hypodensities to predict hematoma expansion. Stroke 49:2067–2073
doi: 10.1161/STROKEAHA.118.022010 pubmed: 30354976 pmcid: 6206864
Li Q, Zhang G, Xiong X et al (2016) Black hole sign: novel imaging marker that predicts hematoma growth in patients with intracerebral hemorrhage. Stroke 47:1777–1781
doi: 10.1161/STROKEAHA.116.013186 pubmed: 27174523
Boulouis G, Morotti A, Brouwers HB et al (2016) Association between hypodensities detected by computed tomography and hematoma expansion in patients with intracerebral hemorrhage. JAMA Neurol 73:961–968
doi: 10.1001/jamaneurol.2016.1218 pubmed: 27323314 pmcid: 5584601
Li Q, Liu QJ, Yang WS et al (2017) Island sign: an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage. Stroke 48:3019–3025
doi: 10.1161/STROKEAHA.117.017985 pubmed: 29018128
Yu Z, Zheng J, Ali H et al (2017) Significance of satellite sign and spot sign in predicting hematoma expansion in spontaneous intracerebral hemorrhage. Clin Neurol Neurosurg 162:67–71
doi: 10.1016/j.clineuro.2017.09.008 pubmed: 28946021

Auteurs

David Rodriguez-Luna (D)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain. david.rodriguez@vallhebron.cat.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain. david.rodriguez@vallhebron.cat.
Blanquerna School of Health Sciences, Ramon Llull University, Barcelona, Spain. david.rodriguez@vallhebron.cat.

Olalla Pancorbo (O)

Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Blanquerna School of Health Sciences, Ramon Llull University, Barcelona, Spain.

Pilar Coscojuela (P)

Department of Neuroradiology, Vall d'Hebron University Hospital, Barcelona, Spain.

Prudencio Lozano (P)

Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Federica Rizzo (F)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Marta Olivé-Gadea (M)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Manuel Requena (M)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Álvaro García-Tornel (Á)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Noelia Rodríguez-Villatoro (N)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Jesús M Juega (JM)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Sandra Boned (S)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Marián Muchada (M)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Jorge Pagola (J)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Marta Rubiera (M)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Marc Ribo (M)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Alejandro Tomasello (A)

Department of Neuroradiology, Vall d'Hebron University Hospital, Barcelona, Spain.

Carlos A Molina (CA)

Department of Neurology, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119, 08035, Barcelona, Spain.
Stroke Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH